Form 8-K - Current report:
SEC Accession No. 0001628280-15-008089
Filing Date
2015-10-30
Accepted
2015-10-30 17:26:26
Documents
3
Period of Report
2015-10-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K CALDOLOR SAFETY 102015 a8kforcaldolorsafety103020.htm 8-K 27578
2 EXHIBIT 99.1 prcaldolorsafety10272015-01.htm EX-99.1 12349
3 copyofcumberlandlogoa02.jpg GRAPHIC 12534
  Complete submission text file 0001628280-15-008089.txt   58339
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 151188582
SIC: 2834 Pharmaceutical Preparations